Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial (Q41657513)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 December 2014

Language	Label	Description	Also known as
English	Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial	scientific article published on 19 December 2014

Statements

scholarly article

1 reference

Europe PubMed Central

6 October 2017

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

6 October 2017

hypertrophic cardiomyopathy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Morten S Jensen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Henning Bundgaard

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Anna Axelsson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Niels Vejlstrup

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Carolyn Ho

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jakob Norsk

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Lasse Langhoff

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Kiril Ahtarovski

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Pernille Corell

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ole Havndrup

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 December 2014

1 reference

Europe PubMed Central

6 October 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

123-131

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Shared genetic causes of cardiac hypertrophy in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan decreases type I collagen synthesis in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an Angiotensin II receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

NT-ProBNP: the mechanism behind the marker

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(14)70241-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41657513&oldid=1925632066"